-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"
Pharmaceutical Network Industry Dynamic" Recently, it was reported that The Shaanxi Provincial Drug Administration, in conjunction with the Shaanxi Provincial Medical Insurance Bureau, carried out a special inspection action for the national drug collection and selection of varietiesIt is worth noting that the focus of the inspection will be on the existence of drug distribution enterprises to take tickets, from illegal channels to purchase drugs, falseVAT invoices and whether to establish a true, accurate, complete, traceable systemIn addition, whether medical institutions can complete the year-round task procurement volume, and ensure that the pharmaceutical production enterprises timely return, and so onIt is understood that the inspection will involve Qilu, green leaves, stone medicine, Huahai, Koren, Yangzijiang and many other well-known pharmaceutical companies of the key varietiesto this, the industry believes that with the drug centralized procurement continues to advance, this time to Shaanxi's supervision as an opportunity, the future drug regulatory bureau and the Health Insurance Bureau to jointly investigate and punish drug circulation and other areas of irregularities or will be replicated throughout the country, to further promote the reform of the pharmaceutical industryin fact, since this year, Jiangsu, Guangxi, Shaanxi, Anhui and other provinces have been introduced in 2020 drug supervision work, which also involves many areasFor example, on April 2nd, according to the Shandong Provincial Drug Administration, it has issued a 2020 provincial drug market supervision and inspection plan, arranged the deployment of drug business and use of the chain of supervision and inspection workAmong them, the inspection plan clearly identified the drug wholesale enterprises, retail chain headquarters and other five types of inspection units of the key content of inspection, closely around the "purchase and sale channel legitimacy, storage and transportation conditions compliance" and other key links that may affect the quality and safety of drugs, and epidemic prevention and control drugs, special drugs and other key varieties to carry out inspectionApril 1, the Sichuan Provincial Drug Administration issued a "Notice on doing a good job in the supervision and inspection of drug circulation in 2020", which also explicitly will strengthen the retail use of drugs, as well as the quality supervision of vaccine storage, transportation and vaccination links, and participate in the supervision and inspection organized by the provincial bureauAt the same time, according to the principle of risk management, the drug business unit to carry out supervision and inspection, according to risk analysis to increase the frequency of inspection, strengthen the inspection, the implementation of extended inspectionThe inspection focuses on the selection of selected drugs, special management drugs, compound preparations containing special drugs, etc., and checks the implementation of drug management laws and regulations by enterprises and the Guiding Principles for on-site inspection of drug management practicescan be seen from the above, the current domestic drug regulatory departments are gradually shifting the focus of work, from the previous promotion of national collection and collection work began to focus on drug regulationIn fact, the industry said that this shift has long been a trend, on July 18 last year, the State issued "on the establishment of professional professional drug inspectors" in the Opinion, has clearly proposed that the drug regulatory departments will be concentrated in the pharmaceutical industry, high-risk drug production gathering and other key areas to strengthen the strength of drug inspection, the implementation of key inspectionProvincial drug regulatory departments shall, in accordance with the needs of regulatory work, strengthen the strength of drug inspection work in areas where drug production is concentrated, and may set up inspection branches in sub-regions where conditions exist, and implement near-inspection and normal inspection In addition to , the opinion also suggests that by the end of 2020, the state drug regulatory department and the provincial drug regulatory department will have basically completed the system of professionalized and specialized drug inspector system From drugs to medical devices to cosmetics, three inspection sequences will be equipped with inspectors to strictly check the relevant violations in general, as drug collection enters normal, regulatory inspection will become the industry's trend For pharmaceutical companies, not only in the production link to continue to strengthen the attention to norms, strengthen management, to ensure that enterprises in the daily production management process more efficient and safe, in the sales and circulation links to ensure compliance development.